share_log

Pfizer | DEFA14A: Others

Pfizer | DEFA14A: Others

辉瑞 | DEFA14A：其他
美股sec公告 ·  03/28 16:17
Moomoo AI 已提取核心信息
Pfizer Inc. has issued a supplement to its proxy statement for the upcoming 2024 Annual Meeting of Shareholders scheduled for April 25, 2024. The supplement, dated March 28, 2024, informs shareholders of the withdrawal of Item 7 – Amend Director Resignation Processes, which will no longer be presented or voted upon at the meeting. Despite the withdrawal of Item 7, Pfizer has confirmed that the previously distributed proxy cards and voting instruction forms remain valid. Shareholders who have already submitted their votes do not need to take any further action unless they wish to change their vote. The supplement emphasizes that all other agenda items are unaffected and votes will be cast accordingly for matters properly brought before the Annual Meeting. Shareholders who have not yet voted are instructed to disregard Item 7 when completing their proxy cards or voting instruction forms.
Pfizer Inc. has issued a supplement to its proxy statement for the upcoming 2024 Annual Meeting of Shareholders scheduled for April 25, 2024. The supplement, dated March 28, 2024, informs shareholders of the withdrawal of Item 7 – Amend Director Resignation Processes, which will no longer be presented or voted upon at the meeting. Despite the withdrawal of Item 7, Pfizer has confirmed that the previously distributed proxy cards and voting instruction forms remain valid. Shareholders who have already submitted their votes do not need to take any further action unless they wish to change their vote. The supplement emphasizes that all other agenda items are unaffected and votes will be cast accordingly for matters properly brought before the Annual Meeting. Shareholders who have not yet voted are instructed to disregard Item 7 when completing their proxy cards or voting instruction forms.
辉瑞公司已发布了定于2024年4月25日举行的2024年年度股东大会的委托书补充文件。该补编于2024年3月28日发布，通知股东撤回第7项——修改董事辞职程序，该项目将不再在会议上提交或表决。尽管撤回了第7项，但辉瑞已确认先前分发的代理卡和投票指示表仍然有效。已经提交选票的股东无需采取任何进一步的行动，除非他们希望更改投票。该补编强调，所有其他议程项目均不受影响，将对适当提交年会的事项进行相应的投票。尚未投票的股东被指示在填写代理卡或投票指示表时忽略第7项。
辉瑞公司已发布了定于2024年4月25日举行的2024年年度股东大会的委托书补充文件。该补编于2024年3月28日发布，通知股东撤回第7项——修改董事辞职程序，该项目将不再在会议上提交或表决。尽管撤回了第7项，但辉瑞已确认先前分发的代理卡和投票指示表仍然有效。已经提交选票的股东无需采取任何进一步的行动，除非他们希望更改投票。该补编强调，所有其他议程项目均不受影响，将对适当提交年会的事项进行相应的投票。尚未投票的股东被指示在填写代理卡或投票指示表时忽略第7项。
有用
没用

该公告为独立文件：

独立文件1  查看翻译

声明：本内容仅用作提供资讯及教育之目的，不构成对任何特定投资或投资策略的推荐或认可。 更多信息